作者 | qian 编辑 | 自动驾驶之心 点击下方 卡片 ，关注" 自动驾驶之心 "公众号 戳我-> 领取 自动驾驶近15个 方向 学习 路线 >>自动驾驶前沿信息获取 → 自动驾驶之心知识星球 本文只做学术分享，如有侵权，联系删文 视觉大语言模型 综述汇总 基础理论 原文链接： https://zhuanlan.zhihu.com/p/1922228114404143784 预训练 智能交通和自动驾驶中的 LLM：https://github.com/ge25nab/Awesome-VLM-AD-ITS AIGC 和 LLM：https://github.com/coderonion/awesome-llm-and-aigc 视觉语言模型综述：https://github.com/jingyi0000/VLM_survey 用于 CLIP 等视觉语言模型的出色提示 / 适配器学习方法：https://github.com/zhengli97/Awesome-Prompt- Adapter-Learning-for-VLMs LLM/VLM 推理论文列表，并附有代码：https://github.com/D ...

Core Viewpoint - O'Reilly Automotive has demonstrated exceptional stock performance, rewarding long-term shareholders significantly, but current valuation raises concerns about future returns for new investors [1][10][12] Group 1: Company Performance - O'Reilly's stock has increased by 502% over the past decade and 57,620% since its IPO in 1993 [1] - The company has shown consistent revenue growth, with a 5.7% year-over-year increase in 2024 and a projected 5.4% growth for the current year [6] - O'Reilly's operating margin has averaged 19.9% over the past decade, indicating strong profitability [7] Group 2: Market Position and Demand - The company benefits from durable demand trends, as vehicle maintenance is necessary regardless of economic conditions [4] - An aging vehicle fleet supports demand for aftermarket auto parts, with the average age of vehicles in the U.S. reaching 12.8 years in 2025, up from 11.5 years a decade ago [5] - O'Reilly's extensive store footprint and brand visibility provide a competitive advantage in a fragmented industry [6] Group 3: Financial Management - O'Reilly's management has effectively utilized excess cash for business expansion and stock buybacks, reducing the outstanding share count by 3% in the last 12 months [7] - The company's stock trades at a price-to-earnings ratio of 34, the highest level since 2000, raising concerns about valuation [10][11] Group 4: Investment Outlook - While O'Reilly possesses favorable investment qualities, the current high valuation suggests that it may not provide life-changing returns for new investors [10][12] - The stock's continued upward trajectory despite valuation concerns indicates market optimism, but investors should consider their own valuation criteria in decision-making [11]

Core Points - A civil trial is set to begin regarding a fatal crash involving a Tesla Model S, where the driver was using the Autopilot feature at the time of the incident [2][10] - The lawsuit claims that Tesla's Autopilot system is defective and unsafe, alleging that the company exaggerated its capabilities while downplaying its deficiencies [9][11] - The judge overseeing the case has allowed claims of design defect and failure to warn against Tesla to proceed, while dismissing claims of manufacturing defect and negligent misrepresentation [10][12] Group 1: Incident Details - The crash occurred in 2019, resulting in the death of Naibel Benavides Leon and serious injuries to Dillon Angulo [1][2] - The Tesla driver, George McGee, stated he was distracted by his phone when the crash happened, impacting the parked Chevrolet Tahoe at approximately 60 miles per hour [2][3] Group 2: Legal Proceedings - The trial is expected to last about three weeks, with Tesla's safety features under scrutiny [3] - The plaintiffs have the potential to seek punitive damages if the jury finds Tesla liable [10][11] - The judge indicated that there is sufficient evidence to suggest that a defect in the Autopilot system was a significant factor in the injuries sustained [11] Group 3: Tesla's Defense - Tesla's legal team argues that the driver was solely responsible for the crash, emphasizing that Autopilot is intended for use by attentive drivers [12][13] - The company maintains that while Autopilot can assist in driving, it does not make the vehicle autonomous and requires driver oversight [12][13] Group 4: Broader Context - Tesla has faced multiple lawsuits regarding its Autopilot software and has been under increased regulatory scrutiny [14] - In previous cases, Tesla has successfully defended itself against claims of liability related to Autopilot, arguing that human error was the primary cause of accidents [15][16]

图片来源： 智谱 据知情人士透露，智谱 AI 正考虑将首次公开募股计划从中国大陆转移至香港。 阿里巴巴集团和腾讯控股投资的智谱 AI 正在与财务顾问合作筹备首次公开募股，可能筹集约 3 亿美 元资金。 智谱最近筹集了来自上海国有风险投资公司及其母公司张江集团的 10 亿元人民币（ 1.39 亿美元）资 金。 知情人士称相关考虑仍在进行中，尚未做出最终决定，并补充说明包括融资规模在内的细节仍可能变 动。智谱 AI 最终仍可能选择在中国大陆上市。 根据向中国证监会提交的 IPO 文件显示，作为少数几家试图在全球范围内挑战 OpenAI 的中国初创企 业之一，智谱 AI 最初准备在中国大陆上市。 香港的交易活动正以权益资本市场交易为主导迎来复苏。根据彭博汇编的数据， 2025 年至今，香港 的首次公开募股和后续发行已筹集约 400 亿美元。这是自 2021 年创纪录年份以来的最高水平，较去 年同期的 57 亿美元大幅跃升。 自Deepseek起以来，智谱及其竞争对手从月之暗面到 MiniMax 都快速推出了低成本的人工智能服 务，旨在在这个蓬勃发展的行业中占据一席之地，并为未来的技术进步制定标准。 https:// ...

Analysts don't expect Nio to reach profitability for years. Should you buy the Chinese automaker's stock anyway?Shares of Chinese electric vehicle (EV) manufacturer Nio (NIO 5.01%) were on the rise for a second straight day on Friday, adding 5.6% through 1 p.m. ET on top of Thursday's 6% gain.You can probably thank Morgan Stanley for that. What Morgan Stanley says about NioIn a note that came out Thursday afternoon, Morgan Stanley analyst Tim Hsiao reiterated his overweight rating on Nio and praised its new ...

that it represents as well. Nvidia, by the way, hit another record this morning. That is the stock.Also this morning, CNBC reporting that Goldman Sachs is piloting an autonomous coder. This is potentially a major step in AI's evolution at least for Wall Street. You sun broke that story.He joins us now to discuss it. So tell us what this is. First of all, Hugh, and how it's going to be used at the bank.>> Hey, David. Yeah. So I mean, I think the headline here is we're in the middle of this grand experiment i ...

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1][2] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point, as stocks can lose momentum when their valuations exceed future growth potential [2] - A safer approach involves investing in bargain stocks that exhibit recent price momentum, which can be identified using the Zacks Momentum Style Score [3] Group 2: Strattec Security (STRT) Analysis - Strattec Security (STRT) has shown a four-week price change of 9.1%, indicating growing investor interest [4] - Over the past 12 weeks, STRT's stock has gained 85.8%, demonstrating its ability to deliver positive returns over a longer timeframe [5] - STRT has a beta of 1.39, suggesting it moves 39% more than the market in either direction, indicating fast-paced momentum [5] - STRT has a Momentum Score of B, suggesting it is an opportune time to invest in the stock [6] - The stock has a Zacks Rank 1 (Strong Buy) due to upward revisions in earnings estimates, which attract more investors [7] - STRT is trading at a Price-to-Sales ratio of 0.49, indicating it is reasonably valued at 49 cents for each dollar of sales [7] Group 3: Additional Investment Opportunities - Besides STRT, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [8] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [9]

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than the traditional "buying low and selling high" approach, aiming for quicker profits [1] Group 1: Momentum Investing Characteristics - Fast-moving trending stocks can be difficult to enter at the right time, as they may lose momentum if future growth does not justify their high valuations [2] - Investing in bargain stocks that have recently shown price momentum can be a safer strategy, utilizing tools like the Zacks Momentum Style Score to identify potential opportunities [3] Group 2: Stoneridge (SRI) Analysis - Stoneridge (SRI) has shown significant price momentum with a four-week price change of 26.4%, indicating growing investor interest [4] - Over the past 12 weeks, SRI's stock has gained 102.7%, with a beta of 1.42, suggesting it moves 42% more than the market [5] - SRI has a Momentum Score of B, indicating a favorable time to invest based on momentum [6] Group 3: Earnings Estimates and Valuation - An upward trend in earnings estimate revisions has contributed to SRI earning a Zacks Rank 2 (Buy), which is associated with strong momentum effects [7] - SRI is trading at a Price-to-Sales ratio of 0.24, indicating it is relatively cheap, as investors pay only 24 cents for each dollar of sales [7] Group 4: Additional Opportunities - Besides SRI, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting further investment opportunities [8] - Various Zacks Premium Screens are available to help identify winning stock picks based on different investing styles [9]

Core Insights - The integration of generative AI and agentic AI in medical devices is transforming clinical workflows and patient care, with generative AI focusing on content creation and design optimization, while agentic AI enables autonomous decision-making based on real-time data [1][3] Group 1: AI Integration in Medical Devices - Generative AI is used to create synthetic medical images for training diagnostic tools, enhancing datasets [1] - Agentic AI supports predictive maintenance in medical equipment, reducing downtime through fault detection and automated service scheduling [3] - AI-powered tools like Nuance Communications's Dragon Ambient eXperience improve clinical documentation by transcribing doctor-patient conversations into structured notes [2] Group 2: Key Factors Driving AI Adoption - There is a rising demand for precision and personalized medicine, with AI enabling individualized diagnostics and treatments based on patient-specific data [5] - The regulatory environment is favorable, with over 700 AI-enabled devices approved by the FDA, significantly increasing from 2020 [6] Group 3: Medical Device Stocks to Watch - Boston Scientific Corporation (BSX) is investing in AI for improved procedural outcomes, with a projected 2025 sales growth rate of 16.4% and earnings expected to grow by 15.9% [8][7] - Johnson & Johnson (JNJ) employs AI in surgical robotics and digital surgery analytics, with a historical earnings growth rate of 5.5% and projected sales growth of 2.8% for 2025 [11][10] - GE HealthCare Technologies Inc. (GEHC) leads in FDA-cleared AI devices, with a projected sales growth rate of 3.2% for 2025 and a focus on enhancing imaging through AI solutions [13][12]

CHENGDU, China, July 11, 2025 (GLOBE NEWSWIRE) -- Maase Inc. (NASDAQ: MAAS) (“MAAS” or the “Company”) today announced that it has signed a non-binding framework agreement with certain shareholders of Qingdao Youdian New Energy Technology Co., Ltd. ("Youdian") and Qingdao Huijulaixi Intelligent Technology Co., Ltd. ("LaiXi") to acquire 100% equity of Youdian and 49% equity of LaiXi. The transaction is expected to close in the third quarter of 2025, marking a pivotal step in MAAS’s strategic expansion into ne ...